NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
0.5910
+0.0010 (0.17%)
Aug 14, 2025, 11:17 AM - Market open
NovaBay Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$0.85
Upside
+43.82%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8 → $0.85 | Strong Buy | Maintains | $8 → $0.85 | +43.82% | Nov 11, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5,206 → $4,900 | Strong Buy | Maintains | $5,206 → $4,900 | +829,003.21% | May 20, 2022 |
Roth Capital | Roth Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 26, 2018 |
Roth Capital | Roth Capital | Strong Buy Initiates $193 | Strong Buy | Initiates | $193 | +32,471.91% | Jun 5, 2017 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $68,906 | Strong Buy | Initiates | $68,906 | +11,659,163.96% | Mar 6, 2013 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $68,906 | Strong Buy | Initiates | $68,906 | +11,659,163.96% | Mar 5, 2013 |